|
MORF4L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.71751501909512E-13 |
| Normal-vs-Stage2 |
7.6637995949369E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.79001258260314E-12 |
| Stage1-vs-Stage2 |
1.957360E-01 |
| Stage1-vs-Stage3 |
1.57221999999013E-05 |
| Stage1-vs-Stage4 |
3.721600E-03 |
| Stage2-vs-Stage3 |
8.271700E-02 |
| Stage2-vs-Stage4 |
3.449600E-01 |
| Stage3-vs-Stage4 |
5.021000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
4.08861833278706E-12 |
| Normal-vs-Asian |
1.257570E-03 |
| Caucasian-vs-AfricanAmerican |
4.848800E-01 |
| Caucasian-vs-Asian |
9.586200E-01 |
| AfricanAmerican-vs-Asian |
8.178400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.63424829224823E-12 |
| Male-vs-Female |
1.708600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.40860000003218E-07 |
| Normal-vs-Age(41-60Yrs) |
2.01105798680601E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(81-100Yrs) |
2.30009999935277E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.513200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.902600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.327400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.802000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.930200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.581200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.797800E-02 |
| Normal-vs-Grade 2 |
1.61739510673442E-11 |
| Normal-vs-Grade 3 |
1.62436730732907E-12 |
| Normal-vs-Grade 4 |
1.62458935193399E-12 |
| Grade 1-vs-Grade 2 |
1.470010E-01 |
| Grade 1-vs-Grade 3 |
3.059100E-03 |
| Grade 1-vs-Grade 4 |
9.027800E-04 |
| Grade 2-vs-Grade 3 |
2.46199999999197E-05 |
| Grade 2-vs-Grade 4 |
1.36399999994818E-06 |
| Grade 3-vs-Grade 4 |
6.953600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.68219948660476E-11 |
| Normal-vs-ccB subtype |
1.62458935193399E-12 |
| ccA subtype-vs-ccB subtype |
7.7593000025189E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63080660087189E-12 |
| Normal-vs-N1 |
6.42590000099474E-08 |
| N0-vs-N1 |
2.003400E-01 |
|
|
